pirtobrutinib
eli lilly
['pirto', 'bruin']
in 80 patients with waldenstr m macroglobulinemia in the phase 1/2 bruin study, pirtobrutinib achieved high levels of response in heavily pretreated patients with wm regardless of prior treatment with a covalent btk inhibitor. #ash22 
Oncology news and insights from leading researchers and cancer centers.